Zusammenfassung
Von der Elektrophysiologie, der Rezeptorausstattung und der Wirkung von Pharmaka her lassen sich 2 Gruppen der glatten Muskulatur differenzieren: intestinaler und vaskulärer Typ. Die glatte Muskulatur des Bronchialsystems nimmt eine Mittelstellung ein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aguilar-Bryan L, Bryan J (1999) Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101–135
Ahlner J, Andersson RGG, Torfgard K, Axelsson KL (1991) Organic nitrate esters: Clinical use and mechanisms of ac- tions. Pharmacol Rev 43:351–423
Anggard E (1994) Nitric oxide: Mediator, murderer, and me- dicine. Lancet 343:1199–1206
Ashcroft FM, Gribble FM (2000) New windows on the mecha- nism of action of K(ATP) channel openers. Trends Phar- macol Sci 21:439–445
Beavo JA (1995) Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 75:725–748
Beech DJ (1997) Actions of neurotransmitters and other messengers on Ca2+ channels and K+ channels in smooth muscle cells. Pharmacol Ther 73:91–119
Berkels R, Klaus W (2000) Kalziumantagonisten näher betrachtet: Eine bekannte Stoffgruppe mit neuartigem Wirkprinzip? Dtsch Med Wochenschr 125:531–533
Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361:315–325
Bootman MD, Berridge MJ (1995) The elemental principles of calcium signaling. Cell 83:675–678
Bugrim AE (1999) Regulation of Ca2+ release by cAMP-dependent protein kinase. A mechanism for agonist-specific calcium. Cell Calcium 25:219–226
Callewaert G (1992) Excitation-contraction coupling in mammalian cardiac cells. Cardiovasc Res 26:923–932
Catterall WA (1995) Structure and function of voltage-gated ion channels. Annu Rev Biochem 64:493–531
Catterall WA, Striessnig J (1992) Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci 13:256–262
Cody RJ (1994) The clinical potential of renin inhibitors and angiotensin antagonists. Drugs 47:586–598
Cooke JP, Dzau VJ (1997) Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med 48:489–509
De Zeeuw D, Janssen WMT, De Jong PE (1992) Atrial natriuretic factor: Its (patho)physiological significance in humans. Kidney Int 41:1115–1133
Dolphin AC (1991) Regulation of calcium channel activity by GTP binding proteins and second messengers. Biochim Biophys Acta 1091:68–80
Elkayam U (1991) Tolerance to organic nitrates: Evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med 114:667–677
Fasolato C, Innocenti B, Pozzan T (1994) Receptor-activated Ca2+ influx: How many mechanisms for how many channels. Trends Pharmacol Sci 15:77–83
Ferro CJ, Webb DJ (1996) The clinical potential of endothelin receptor antagonists in cardiovascular medicine. Drugs 51:12–27
Fleckenstein A (1983) History of calcium antagonists. Circ Res 52 [Suppl I]:3–16
Förstermann U (1994) Biochemistry and molecular biology of nitric oxide synthases. Arzneimittelforschung 44: 402–407
Förstermann U, Boissel JP, Kleinert H (1998) Expressional control of the „constitutive“ isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12:773–790
Frey A, Reif A, Zabel U, Schmidt HH (1998) NO: 10 years after. Biospektrum 2:27–32
Friebe A, Schultz G, Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15:6863–6868
Fukata Y, Amano M, Kaibuchi K (2001) Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22:32–39
Galen PJM van, Stiles GL, Michaels G, Jacobson KA (1992) Adenosin A1 and A2 receptors: Structure-function relationships. Med Res Rev 12:423–471
Garbers DL, Koesling D, Schultz G (1994) Guanylyl cyclase receptors. Mol Biol Cell 5:1–5
Gerzer R (1985) Das Herz, ein endokrines Organ: Die Entdeckung eines neuen Hormons. Klin Wochenschr 63:529–536
Glossmann H, Striessnig J (1990) Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol 114:1 -105
Goldmann B, Stoltefuss J (1991) 1,4-dihydropyridines: Effects of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew Chem (Int Ed Engl) 30:1559–1578
Goldstein I, Lue TF, Padma-Nathan H. Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafìl in the treatment of erectile dysfunction. N Engl J Med 20:1397–1404
Griendling KK, Lassègue B, Alexander RW (1996) Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 36:281–306
Grobecker H (1994) Calciumantagonisten. Med Monatsschr Pharm 17:130–139
Harteneck C, Plant TD, Schultz G (2000) From worm to man: Three subfamilies of TRP channels. Trends Neurosci 23:159–166
Hellwig B (1994) Kaliumagonisten. Med Monatsschr Pharm 17:164–167
Hockerman GH, Peterson BZ, Johnson BD, Catterall WA (1997) Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 37:361–396
Hofmann F, Biel M, Flockerzi V (1994) Molecular basis for Ca2+ channel diversity. Annu Rev Neurosci 17:399–418
Hollenberg MD (1994) Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 15:108–114
Horowitz A, Menice CB, Laporte R, Morgan KG (1996) Mechanisms of smooth muscle contraction. Physiol Rev 76:967–1003
Kam PCA, Govendeer G (1994) Nitric oxide: Basic science and clinical applications. Anaesthesia 49:515–521
Kamm KE, Stull JT (1985) The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25:593–620
Levin ER (1995) Endothelins. N Engl J Med 333:356–363
Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 5:321–328
Masaki T (1995) Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol 35:235–255
Matsusaka T, Ichikawa I (1997) Biological functions of angiotensin and its receptors. Annu Rev Physiol 59:395–412
Means AR, VanBerkum MFA, Bagchi I, Lu KP, Rasmussen CD (1991) Regulatory functions of calmodulin. Pharmacol Ther 50:255–270
Mikoshiba K (1997) The InsP3 receptor and intracellular Ca2+ signaling. Curr Opin Neurobiol 7:339–345
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
Nathan C, Xie QW (1994) Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725–13728
Orallo F (1996) Regulation of cytosolic calcium levels in vascular smooth muscle. Pharmacol Ther 69:153–171
Pfaffendorf M (1992) Atriales natriuretisches Peptid als Angiotensin-II-Antagonist: Eine neues therapeutisches Prinzip? Med Monatsschr Pharm 15:169–177
Pfaffendorf M (1996) Das Endothel als sekretorisches Organ. Med Monatsschr Pharm 19:42–53
Pietrobon D, Di Virgilio F, Pozzan T (1990) Structural and functional aspects of calcium homeostasis in eukaryotic cells. Eur J Biochem 193:599–622
Pinto-Sietsma SJ, Paul M (1998) A role for endothelin in the pathogenesis of hypertension: Fact or fiction? Kidney Int 54 Suppl 67:115–121
Po AL, Zhang WY (1998) What lessons can be learnt from withdrawal of mibefradil from the market? Lancet 351:1829–1830
Pongs O (1992) Structural basis of voltage-gated K+-channel pharmacology. Trends Pharmacol Sci 13:359–365
Quayle JM, Standen NB (1994) K-ATP channels in vascular smooth muscle. Cardiovasc Res 28:797–804
Rembold CM (1992) Regulation of contraction and relaxation in arterial smooth muscle. Hypertension 20:129–137
Reynen K (1993) Nitrate. Dtsch Med Wochenschr 118:1532–1539
Scherübl H, Hescheler J (1992) Patch-clamp-Technik und Ionenkanäle: Bedeutung in der Medizin. Dtsch Ärztebl 89:B-215-B–218
Schlossmann J, Ammendola A, Ashman K, Zong X, Huber A, Neubauer G, Wang GX, Allescher HD, Korth M, Wilm M, Hofmann F, Ruth P (2000) Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 404:197–201
Schmidt HHHW (1994) NO, endogener Botenstoff und Zellgift. Med Monatsschr Pharm 17:168–185
Schröder H (1992) Organische Nitrate: Neue Erkenntnisse zum Wirkungsmechanismus einer alten Substanzklasse. Med Monatsschr Pharm 15:134–139
Seasholtz TM, Majumdar M, Brown JH (1999) Rho as a mediator of G protein-coupled receptor signaling. Mol Pharmacol 55:949–956
Smyth EM, Keenan AK (1994) The vascular ANF-C receptor: Role in atrial peptide signalling. Cell Signal 6:125–133
Somlyo AP, Somlyo AV (2000) Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522.2:177–185
Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H (1998) Structural basis of drug binding to L Ca2+-channels. Trends Pharmacol Sci 19:108–115
Sutko JL, Airey JA, Welch W, Ruest L (1997) The pharmacology of ryanodine and related compounds. Pharmacol Rev 49:53–98
Tang W-J, Gilman AG (1992) Adenylyl cyclases. Cell 70:869–872
Thompson WJ (1991) Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function. Pharmacol Ther 51:13–33
Zucchi R, Ronca-Testoni S (1997) The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: Modulation by endogenous effectors, drugs and disease states. Pharmacol Rev 49:1–51
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Oberdisse, E. (2002). Pharmaka mit Wirkung auf den glatten Muskel. In: Oberdisse, E., Hackenthal, E., Kuschinsky, K. (eds) Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56314-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-56314-0_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62634-0
Online ISBN: 978-3-642-56314-0
eBook Packages: Springer Book Archive